Ashley Rombough
Family · Cooperstown, NYNPI 1669945390
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,767 of the $3,261 with a category attached, or 84.9%. It is spread thinly across 34 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,102 and has fallen 76.6% since, to $258 in 2025. Among family clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $21.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$738
- E.r. Squibb & Sons, L.L.C.$432
- Astellas Pharma US Inc$407
- Amgen$254
- Incyte Corporation$152
- Seagen Inc.$143
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,76785%
- Education$49415%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 37 | $738 |
| E.r. Squibb & Sons, L.L.C. | 15 | $432 |
| Astellas Pharma US Inc | 6 | $407 |
| Amgen | 11 | $254 |
| Incyte Corporation | 11 | $152 |
| Seagen Inc. | 4 | $143 |
| Novartis | 8 | $138 |
| AbbVie | 6 | $103 |
| Beigene USA, Inc. | 7 | $102 |
| Merck | 7 | $101 |
| Karyopharm Therapeutics Inc. | 6 | $86 |
| GSK | 4 | $74 |
| Eisai Inc. | 3 | $52 |
| Taiho Oncology, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Pharmacosmos Therapeutics Inc. | 2 | $33 |
| Mirati Therapeutics, Inc. | 2 | $31 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Bayer | 2 | $31 |
| CTI Biopharma Corp. | 2 | $30 |
| G1 Therapeutics, Inc. | 2 | $29 |
| Beone Medicines USA, Inc. | 1 | $26 |
| Adaptive Biotechnologies Corporation | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Dendreon Pharmaceuticals LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| EMD Serono, Inc. | 1 | $17 |
| Geron Corporation | 1 | $15 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $15 |
| Sobi, Inc | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Servier Pharmaceuticals LLC | 1 | $13 |
| Bristol Myers Squibb | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,261 in reported general payments places this provider in the 90th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $14,892 |
| Pantoprazole Sodium | 46 | $549 |
| Dexamethasone | 16 | $448 |
| Atorvastatin Calcium | 24 | $230 |
| Levothyroxine Sodium | 19 | $156 |
| Lisinopril | 13 | $55 |
Paid to pharmacies, not to this prescriber.
Other family in Cooperstown
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.